- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Brisdelle (paroxetine mesylate)
Total 1905 results
-
Noven TherapeuticsCompleted
-
Noven TherapeuticsCompleted
-
Noven TherapeuticsCompleted
-
Noven TherapeuticsCompletedPostmenopausal SymptomsUnited States
-
Eisai LimitedCompleted
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma,DLBCLChina
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
Novartis PharmaceuticalsCompletedRefractory Desmoplastic Small Round Cell TumorsItaly
-
GlaxoSmithKlineCompletedDepressive DisorderKorea, Republic of, Japan
-
IlDong Pharmaceutical Co LtdCompletedHealthyKorea, Republic of
-
GlaxoSmithKlineTerminatedDepressive DisorderJapan
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSexual Dysfunction | Ejaculation
-
Alza Corporation, DE, USACompletedSexual Dysfunction | Erectile Dysfunction | Ejaculation
-
Johnson & Johnson Pte LtdCompletedSexual Dysfunction, PhysiologicalKorea, Republic of, Australia, Thailand
-
Alza Corporation, DE, USACompleted
-
Janssen Research & Development, LLCCompletedSexual Dysfunction, Physiological | EjaculationGermany, Spain, Portugal, Finland, Sweden, Austria
-
Cedars-Sinai Medical CenterPfizerTerminatedAnxiety DisordersUnited States
-
Pusan National University HospitalUnknownPremature EjaculationKorea, Republic of
-
Yuhan CorporationCompletedPremature EjaculationKorea, Republic of
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Alza Corporation, DE, USACompleted
-
GlaxoSmithKlineCompletedDepressive DisorderJapan
-
Janssen Research & Development, LLCCegedim Strategic DataCompletedSexual Dysfunction, Physiological
-
Nanjing First Hospital, Nanjing Medical UniversityEnrolling by invitationMain Heading (Descriptor) TermsChina
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
Eisai Inc.Completed
-
Eisai Co., Ltd.Completed
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Eisai Korea Inc.CompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
Merz Pharmaceuticals GmbHTerminatedSubjective TinnitusUnited States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
-
Pathway Therapeutics, Inc.Completed
-
Merz Pharmaceuticals GmbHTerminatedMultiple Sclerosis | Nystagmus, Congenital | Nystagmus, AcquiredUnited Kingdom
-
Merz Pharmaceuticals GmbHCompleted
-
Centre Leon BerardCompletedGastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene MutationFrance
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTriple Negative Breast CancerChina
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusUnited States, Austria, Germany, Brazil, Mexico
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusBelgium, Czech Republic, France, Poland, South Africa, Netherlands
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Eisai Inc.Completed
-
Eisai Inc.Children's Oncology GroupCompleted
-
Chang Gung Memorial HospitalEisai Co., Ltd.; Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)UnknownAdvanced Breast Cancer | Metastatic Breast CancerTaiwan
-
Eisai Co., Ltd.Completed
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusGermany, Portugal, Spain, United Kingdom, Austria
-
Eisai Inc.Completed
-
Hunan Cancer HospitalCompletedMetastatic Breast CancerChina
-
Oncologia Medica dell'Ospedale FatebenefratelliMario Negri Institute for Pharmacological ResearchCompletedMetastatic Breast Cancer | Toxicity | Neurotoxicity | Adverse Drug Event | Drug ToxicityItaly
-
InteKrin Therapeutics, Inc.CompletedDiabetes Mellitus, Type IIUnited States